Clinical Kidney Journal

Article	Citations
An introduction to inverse probability of treatment weighting in observational research	173
Coronavirus disease 2019 in chronic kidney disease	56
The ERA Registry Annual Report 2019: summary and age comparisons	54
Conducting correlation analysis: important limitations and pitfalls	52
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis	46
RICORS2040: the need for collaborative research in chronic kidney disease	43
Bone mineral density and mortality in end-stage renal disease patients	35
Kidney disease and electrolytes in COVID-19: more than meets the eye	33
Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients	32
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	31
Fiber intake and health in people with chronic kidney disease	31
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose	29
Oxalate nephropathy: a review	27
Epidemiology and burden of chronic kidney disease-associated pruritus	27
Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine	26
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study	26
Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019	24
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care	23
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant	23
Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects	22
Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019	21
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches	21
Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4	20
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics	20
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease	20

De novo and relapsing necrotizing vasculitis after COVID-19 vaccination	20
Unravelling the pathophysiology of chronic kidney disease-associated pruritus	19
Acute kidney injury in COVID-19: multicentre prospective analysis of registry data	19
An introduction to joint models—applications in nephrology	19
Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls	19
Hypophosphatemia in cancer patients	18
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination	17
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	16
Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury	16
Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study	16
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure	15
Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients	15
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	15
Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation	15
Burnout and long COVID among the UK nephrology workforce: results from a national survey investigating the impact of COVID-19 on working lives	14
Correlations, agreement and utility of frailty instruments in prevalent haemodialysis patients: baseline cohort data from the FITNESS study	14
The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management	14
Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation	14
Point-of-care testing technologies for the home in chronic kidney disease: a narrative review	14
Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination	14
The rapid development of a novel kidney-specific digital intervention for self-management of physical activity and emotional well-being during the COVID-19 pandemic and beyond: Kidney Beam	14
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis	14
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice	13
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination	13
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	13
Multitargeted interventions to reduce dialysis-induced systemic stress	13
Albumin is an interface between blood plasma and cell membrane, and not just a sponge	13
Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study	13
Comparison of four medium cut-off dialyzers	13
The Latin American Dialysis and Renal Transplantation Registry: report 2019	13
Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria	13
Outcomes and predictors of skin sodium concentration in dialysis patients	12
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy	12
Early and late acute kidney injury: temporal profile in the critically ill pediatric patient	12
The Many Faces of NELL1 MN	12
Targeting complement in severe coronavirus disease 2019 to address microthrombosis	12
Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study	12
More on the invisibility of chronic kidney disease… and counting	12
Association of leukocyte telomere length with chronic kidney disease in East Asians with type 2 diabetes: a Mendelian randomization study	12
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis	12
Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved	12
The utility of remote patient management in peritoneal dialysis	12
Clinical outcomes of hemodialysis patients infected with severe acute respiratory syndrome coronavirus 2 and impact of proactive chest computed tomography scans	12
Tirzepatide and prevention of chronic kidney disease	12
Primary hyperoxaluria type 1: pathophysiology and genetics	12
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study	11
Development and external validation of an acute kidney injury risk score for use in the general population	11
Decreasing microbiota-derived uremic toxins to improve CKD outcomes	11
Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines	11
Nicotinamide and acute kidney injury	11

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art	11
Blood pressure targets in CKD 2021: the never-ending guidelines debacle	11
Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients	11
Application of the Clinical Frailty Score and body composition and upper arm strength in haemodialysis patients	10
Development and internal validation of a Wasp Sting Severity Score to assess severity and indicate blood purification in persons with Asian wasp stings	10
Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study	10
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study	10
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation	10
Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease	10
Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics	10
Robot-assisted kidney transplantation: an update	10
Primary hyperoxaluria type 1: novel therapies at a glance	10
Treatment of primary hyperoxaluria type 1	10
Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?	9
Frailty among chronic kidney disease patients on the kidney transplant waiting list: the sex–frailty paradox	9
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients	9
The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years	9
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease	9
ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature	9
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy	9
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence	9
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients	9
Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine	9
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors	9
Adult-onset nephrotic syndrome following coronavirus disease vaccination	9
Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach	9
The syndrome of inappropriate antidiuresis in COVID-19 pneumonia: report of two cases	9
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	9
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	9
Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis	8
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy	8
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	8
Randomized comparison of three high-flux dialyzers during high-volume online hemodiafiltration—the comPERFORM study	8
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes	8
Immune abnormalities in IgA nephropathy	8
Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease	8
Thiazide diuretics are back in CKD: the case of chlorthalidone	8
Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data	8
The ERA Registry Annual Report 2020: a summary	8
Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients	8
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	8
The relationship between chronic kidney disease–associated pruritus and health-related quality of life: a systematic review	8
Acute interstitial nephritis following SARS-CoV-2 vaccination	8
Increased LDL-cholesterol level is associated with deterioration of renal function in males	8
Acute interstitial nephritis after messenger RNA-based vaccination	8
Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease	8
Operational considerations for peritoneal dialysis management during the COVID-19 pandemic	8
Influence of doctors’ perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China	8
Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study	8
A functional TGFB1 polymorphism in the donor associates with long-term graft survival after kidney transplantation	8
Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study	8
Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in Spain	8
Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis	7
PoCUS in nephrology: a new tool to improve our diagnostic skills	7
Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic	7
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction	7
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	7
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression	7
Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort stud	7
Contemporary outcomes of anemia in US patients with chronic kidney disease	7
Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study	7
Ageing meets kidney disease	7
Stability and compatibility of antibiotics in peritoneal dialysis solutions	7
Idiopathic nephrotic syndrome relapse following COVID-19 vaccination: a series of 25 cases	7
Management of fracture risk in CKD—traditional and novel approaches	7
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study	7
Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab	7
Long-term effect of COVID-19 infection on hemodialysis patients: Should we follow hemodialysis patients more closely?	7
Higher ambient nitrogen dioxide is associated with an elevated risk of hospital-acquired acute kidney injury	7
New and old GFR equations: a European perspective	7
New aspects in cardiorenal syndrome and HFpEF	7
Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review	7
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patient	7
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia	7
Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction	7
Comparative efficacy of patiromer and sodium polystyrene sulfonate on potassium levels in chronic haemodialysis patients: a randomized crossover trial	7
Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease	7
Women's representation in clinical trials of patients with chronic kidney disease	6
Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't	6
The membrane perspective of uraemic toxins: which ones should, or can, be removed?	6

Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease	6
Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease	6
In vitro elimination of anti-infective drugs by the Seraph® 100 Microbind® affinity blood filter	6
Peritoneal dialysis–first initiative in India: a cost-effectiveness analysis	6
Pseudo-acute kidney injury secondary to tepotinib	6
The tryptophan pathway and nicotinamide supplementation in ischaemic acute kidney injury	6
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	6
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	6
The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait	6
Expanded hemodialysis: what’s up, Doc?	6
The scientific principles and technological determinants of haemodialysis membranes	6
Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine	6
Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function	6
Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification	6
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort	6
Treatment of acute kidney injury in cancer patients	6
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?	6
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin	6
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D	6
Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination	6
Outcomes of patients with COVID-19 on kidney replacement therapy: a comparison among modalities in England	6
Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Associatio	6
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs	6
Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?	6
Subtyping hospitalized patients with hypokalemia by machine learning consensus clustering and associated mortality risks	6
The misuse of funnel plots in meta-analyses of proportions: are they really useful?	6
Long-term impact of COVID-19 among maintenance haemodialysis patients	6
First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2	6
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	6
Achieving consensus on psychosocial and physical rehabilitation management for people living with kidney disease	6
Time-updated anion gap and cardiovascular events in advanced chronic kidney disease: a cohort study	6
Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	5
Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy	5
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients	5
Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study	5
Long-term exposure to air pollutants and increased risk of chronic kidney disease in a community-based population using a fuzzy logic inference model	5
Integrating electronic health data records to develop and validate a predictive model of hospital-acquired acute kidney injury in non-critically ill patients	5
A roadmap to parathyroidectomy for kidney transplant candidates	5
How to manage cigarette smoking in kidney transplant candidates and recipients?	5
A treasure from a barren island: the discovery of rapamycin	5
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury	5
Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort	5
The association of glucose metabolism and kidney function in middle-aged adults	5
Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?	5
Serum bilirubin and kidney function: a Mendelian randomization study	5
An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits	5
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	5
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study	5
Probiotics for kidney disease	5
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications	5
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	5
Native BK virus nephropathy in lung transplant: a case report and literature review	5
Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against haemodialysis patients	5
Severe acute respiratory SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience	5
Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era	5
2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis	5
Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury	5
Systematic reporting of medical kidney biopsies	5
Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999–2018 National Health and Nutrition Examination Survey	5
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients	5
Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome	5
Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease	5
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	5
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registry	5
Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment	5
Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine	5
Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients	5
Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor	5
Increased mortality after kidney transplantation in mildly frail recipients	5
Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis	5
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease	5
Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events	5
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease	5
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis	5
De novo IgA vasculitis following adenovirus-based SARS-CoV-2 vaccination	4
Sugar-sweetened beverage consumption and mortality of chronic kidney disease: results from the US National Health and Nutrition Examination Survey, 1999–2014	4
COVID-19 vaccination precipitatingde novoANCA-associated vasculitis: clinical implications	4
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis	4
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	4
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	4
COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?	4
Gender distribution in presidents and board members of European nephrology societies	4
National survey on genetic test prescription in French adult nephrologists: a call for simplification and education	4
Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis	4
Patiromer utilization in patients with advanced chronic kidney disease under nephrology care in Germany	4
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patients	4
Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland	4
The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis	4
Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population	4
Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability	4
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients	4
PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations	4
Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease	4
Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study	4
Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population	4